SABS
#3656
SAB Biotherapeutics, Inc. Common Stock
4.05 USD
+4.92%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
Faixa anual
Mudança diária
+4.92%
Mudança mensal
-5.15%
Mudança em 6 meses
+75.32%
Mudança anual
+202.24%
Fechamento anterior
3.86
Abrir
4.05
Bid
Ask
Mínimo
4.05
High
4.05
Volume
10
Financials
- Market Capitalization 206.35 M
- Employee 86
- Founded 2014
- CEO N/A
- Website www.sab.bio
- Headquarter Delaware, United States
- FIGI BBG00YHY0G24
- Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
206.35 M Market capitalization
Price to earnings ratio
-4.73
Price to sales ratio
—